期刊文献+

2010—2012年万古霉素对耐甲氧西林金黄色葡萄球菌MIC值的变化 被引量:2

Vancomycin MIC values in methicillin-resistant Staphylococcus aureus clinical isolates from 2010 to 2012
下载PDF
导出
摘要 目的了解万古霉素对不同标本来源的耐甲氧西林金黄色葡萄球菌(MRSA)最低抑菌浓度(MIC)值的变化。方法收集某院2010—2012年临床分离的MRSA菌株,测定MRSA万古霉素MIC值;并按不同标本来源,对菌株万古霉素MIC值进行分析。结果 3年共收集金黄色葡萄球菌1 434株,其中分离自痰标本857株,血液标本239株,其他标本338株;2010—2012年MRSA检出率分别为41.12%(169/411)、44.96%(214/476)和48.08%(263/547)。2010—2012年血液标本分离的金黄色葡萄球菌MRSA检出率分别为29.03%、30.86%、30.21%,痰标本分离的金黄色葡萄球菌MRSA检出率分别为46.89%、51.03%、57.10%;3年间痰标本MRSA检出率均高于血液标本(χ2值分别为6.41、10.36、21.43,均P<0.05)。血液及痰标本分离的MRSA对万古霉素均敏感。2010—2012年血液标本分离的MRSA万古霉素MIC≥1.00μg/mL菌株分别占38.89%(7株)、40.00%(10株)及37.93%(11株),3年间比较,差异无统计学意义(χ2=0.02,P=0.999);痰液分离的MRSA万古霉素MIC≥1.00μg/mL菌株分别占36.28%(41株)、40.94%(61株)及49.73%(92株),3年比较,差异亦无统计学意义(χ2=5.72,P=0.057)。结论该院2010—2012年临床MRSA检出率呈增高趋势。痰标本的MRSA检出率及万古霉素MIC值有所增高;血液标本的MRSA检出率及万古霉素MIC变化不明显。 Objective To analyze vancomycin minimum inhibitory concentration(MIC)in methicillin-resistant Staphylococcus aureus(MRSA)isolated from different clinical specimens.Methods From2010 to 2012,MRSA were identified and vancomycin MIC in MRSA was determined by VITEK2 COMPACT;vancomycin MIC values were analyzed.Results A total of 1 434 isolates of Staphylococcus aureus were detected,including 857 sputum specimens,239 blood specimens,and338 other specimens;MRSA isolation rate of all specimens was 41.12%(169/411),44.96%(214/476)and 48.08%(263/547)respectively.MRSA isolation rate of blood specimens was29.03%,30.86%and 30.21%respectively,and sputum was 46.89%,51.03% and 57.10% respectively;MRSA isolation rate of sputum was higher than that of blood specimens(χ2= 6.41,10.36,21.43 respectively,all P0.05).All strains were sensitive to vancomycin.The percentage of vancomycin MIC≥1.00μg/mL in MRSA from blood specimens was 38.89%(7 isolates),40.00%(10 isolates)and 37.93%(11 isolates)in 2010-2012 respectively(χ2=0.02,P=0.999),and from sputum specimens was 36.28%(41 isolates),40.94%(61 isolates)and 49.73%(92isolates)respectively(χ2=5.72,P=0.057).Conclusion The detection rate of MRSA clinical isolates has shown an increased trend from2010 to 2012.Detection rate of MRSA from sputum was higher than that of blood specimens;detection rate and vancomycin MIC value of MRSA from sputum specimens increased a little;detection rate and vancomycin MIC value of blood specimens didn't change obviously.
机构地区 株洲市一医院
出处 《中国感染控制杂志》 CAS 2013年第5期344-346,350,共4页 Chinese Journal of Infection Control
关键词 金黄色葡萄球菌 耐甲氧西林金黄色葡萄球菌 万古霉素 最低抑菌浓度 医院感染 合理用药 Staphylococcus aureus methicillin-resistant Staphylococcus aureus vancomycin minimum inhibitory concentration healthcare-associated infection rational drug use
  • 相关文献

参考文献8

  • 1Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-interrnediate Staphylococcus aureus (VISA), vancornycin-suseeptible clinical rnethicillin-resistant S. aureus (MRSA) blood isolates from 2001 - 2005[J]. J Antirnicrob Chemother, 2007,60(4) :788 - 794.
  • 2Sakoulas G, Moise-Broder P A, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancornycin for treatment of rnethicillin-resistant Staphylococcus aureus bacte- rernia[J]. J Clin Microbiol,2004, 42(6) :2398 - 2402.
  • 3Ho P L, Lo P Y, Chow K H, et a l. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong[J]. J Infect,2010, 60(11 ) : 140 - 145.
  • 4张光艳,卓超,黎晓强.2007—2009年金黄色葡萄球菌对万古霉素MIC值变化的研究[J].中国抗生素杂志,2011,36(9):699-702. 被引量:19
  • 5梁晶晶,吴本权,朱家馨,周宇麒,张天托.万古霉素对下呼吸道分离的耐甲氧西林金黄色葡萄球菌MIC漂移的研究[J].中华医院感染学杂志,2011,21(23):4885-4887. 被引量:6
  • 6Cruciani M, Gattr G, Lazzarini L, et al. Penetration of vanco- mycin into human lung tissue[J]. J Antimicrob Chemother, 1996,38~865 - 869.
  • 7Haque N Z,Zuniga L C,Peyrani P,et al. Relationship of van- comycin minimum inhibitory concentration to mortality in pa tients with methicillin-resistant Staphylococcus aureus hospi- tal-acquired, ventilator-associated, or healthcare-assoeiated pneumonia[J]. Chest,2010, 138(6) : 1356 - 1362.
  • 8Lodise T P, Graves J, Evans A, et al. Relationship between vaneomyein MIC and failure among patients with methicillin- resistant Staphylococcus aureus bacteremia treated with vaneo- myein[J]. Antimicrob Agents Chemother, 2008,52(9) : 3315 - 3320.

二级参考文献18

  • 1Sievert D M, Rudrik J T, Patel J B, et al . Vancomycin-Resistant Staphylococcus aureus in the United States, 2002- 2006[J]. Clin Infect Dis, 2008, 46(5): 668-741.
  • 2Steinkraus G, White R, Friedrich L, et al. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05[J] JAntimicrob Chemother, 2007, 60(4): 788-794.
  • 3Wang G Q, Hindler J F, Ward K W, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a University Hospital during a 5-Year period[J]. J Clin Microbiol, 2006, 44(11): 3883-3886.
  • 4Lodise T P, Graves J, Evans A, et al. Relationship between Vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bactere-mia treated with vancomycin[J]. Antimicrob Agents Chemother, 2008, 52(9): 3315-3320.
  • 5Haque N Z,Zuniga L C, Reyes K, et al. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-careassociated pneumonia[J]. Chest, 2010, 138(6): 1356-1362.
  • 6Performance standards for antimicrobial susceptibility testing[M]. Wayne. Clinical and Laboratory Standards Institute. 2008: 46-53.
  • 7Soriano A, Marco F, Martinez J A, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia[J]. Clin Infect Dis, 2008, 46( 11): 193-200.
  • 8Ho P L, Lo P Y, Chow K H, et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong[J]. Jlnfect, 2010, 60(11): 140-145.
  • 9Sader H S, Fey P D, Limaye A P, et al. Evaluation of vancomycin and daptomycin potency trends (MIC Creep) against methicillin-resistant Staphylococcus aureus isolates collected in Nine U.S. Medical Centers from 2002 to 2006[J]. Antimicrob Agents Chemother, 2009, 53(10): 4127-4132.
  • 10Golan Y, McDermott L, Perry L, et al. Changes in linezolid susceptibility among consecutive 1S0 Co lates[C]//Abstracts nference on Antimic of the Forty MRSA -sixth bacteremia Interscience robial Agents and Chemotherapy, San Francisco, CA, 2006. Washington, DC, USA:American Society for Microbiology, 2006.

共引文献21

同被引文献16

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部